PMID: 9647349Jul 1, 1998Paper

Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers

Pharmaceutical Research
Elena V BatrakovaAlexander V Kabanov

Abstract

The present work characterizes the effects of Pluronic copolymers on the transport of a P-gp-dependent probe, rhodamine 123 (R123) in Caco-2 cell monolayers. The accumulation and efflux studies were performed on the confluent Caco-2 monolayers using fluorescent probes with and without Pluronic copolymers. At concentrations below the critical micelle concentration single chains ("unimers") of Pluronic P85 enhanced the accumulation and inhibited the efflux of R123 in Caco-2 monolayers. The transport of the P-gp-independent probe, rhodamine 110 was not altered under these conditions. In contrast the micelles increased R123 accumulation to a much lower extent when compared to the unimers and enhanced R123 efflux in Caco-2 monolayers. Pluronic P85 unimers increase accumulation of a P-gp-dependent drug in Caco-2 monolayers through inhibition of the P-gp efflux system. The mechanism of the micelle effect is not known, however, it is very similar to the micelle effects in BBMEC. This has been previously shown to involve vesicular transport of the micelle-incorporated drug. The study suggests that Pluronic copolymers can be useful in increasing oral absorption of select drugs.

Citations

Dec 1, 2001·Expert Opinion on Biological Therapy·V AlakhovA Kabanov
Oct 17, 2003·Archives of Pharmacal Research·Hongjian ZhangSaeho Chong
Sep 27, 2007·Pharmaceutical Research·Martin Werle
Jul 12, 2014·Drug Delivery·Prabhjot KaurAmit K Goyal
Apr 5, 2014·The Journal of Pharmacy and Pharmacology·Yue ZhouJin Deng
May 15, 2002·Pharmacology & Toxicology·Gert Fricker, David S Miller
Dec 29, 2004·Journal of Drug Targeting·Serguei V VinogradovAlexander V Kabanov
Aug 5, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Xiaobin ZhangAlexander V Kabanov
Feb 7, 2012·ChemSusChem·Sanna Kotrappanavar NatarajKuei-Hsien Chen
Aug 9, 2013·Biological & Pharmaceutical Bulletin·Yong-Qiang ShanJian-Dong Jiang
May 1, 2008·Expert Review of Clinical Pharmacology·Martin WerleAndreas Bernkop-Schnürch
Jan 21, 2017·Membranes·Zahra Ghassemi, Gymama Slaughter
Jan 18, 2003·Pharmacology & Toxicology·Guo-yu PanYuan-Yuan Xie
Aug 9, 2006·Journal of Lipid Research·Sumbul FatmaM Mahmood Hussain
Dec 24, 2005·Expert Opinion on Drug Delivery·Hamidreza Montazeri Aliabadi, Afsaneh Lavasanifar
Sep 12, 2008·Clinical Pharmacokinetics·Hamidreza Montazeri AliabadiAfsaneh Lavasanifar
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter
Sep 7, 2018·Drug Delivery and Translational Research·Linlin MiaoXing Tang
Oct 11, 2015·The Journal of Pharmacy and Pharmacology·Xinru LiGuiling Li
Sep 10, 2014·Colloids and Surfaces. B, Biointerfaces·Masoud RahmanPieter Stroeve
Aug 15, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander V KabanovValery Yu Alakhov
Sep 3, 2002·Advanced Drug Delivery Reviews·Alexander V KabanovValery Yu Alakhov
Feb 15, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lev Bromberg, Valery Alakhov
Apr 6, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bart LucasJoseph Demeester
Dec 1, 2004·Basic & Clinical Pharmacology & Toxicology·Yongchuan GuJianguo Sun
Jul 25, 2006·International Journal of Pharmaceutics·S Sajeesh, Chandra P Sharma
Feb 3, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chien-Wen ChangSung Wan Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.